GTG Genetic Technologies Limited

Genetic Technologies Limited (NASDAQ GM: GENE; ASX: GTG) today announced that, following the recent appointment of Mr. David Carruthers as a Director of the Company and as Chairman of its Audit Committee, Nasdaq has confirmed that the Company�s brief non-compliance with Marketplace Rule 4350(d)(2), as announced on January 12, 2007, has now been rectified. Accordingly, this matter is now closed. ABOUT GENETIC TECHNOLOGIES: Genetic Technologies is a leading Australian life science company, specializing in the fields of genetics and genomics. The company's methods and processes through which non-coding DNA can be analyzed and applied have been patented in 24 countries and form the basis of worldwide licensing activities.